MEN1 and leukemia: Despite the observation that KMT2A genomic alterations (except KMT2A‐rearrangements in leukemia) seem to have no overall impact on the prognosis of cancer patients, the integrity and function of the KMT2A/Menin complex seems to be important in a variety of cancer types.